Other OTC Pharmaceuticals (Pharmacies) - Panama

  • Panama
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$14.65m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.16%, resulting in a market volume of US$16.30m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.24 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Panama is experiencing steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Panama are increasingly seeking out over-the-counter (OTC) pharmaceutical products for self-medication and minor health issues. This shift in preference can be attributed to several factors. Firstly, the convenience and accessibility of OTC products in pharmacies make them an attractive option for consumers who want immediate relief without the need for a doctor's prescription. Additionally, the rising healthcare costs and long waiting times in hospitals and clinics have further encouraged consumers to rely on OTC medications for common ailments. Moreover, the growing awareness about preventive healthcare and the importance of early intervention has also contributed to the increased demand for OTC pharmaceuticals.

Trends in the market:
One key trend in the Other OTC Pharmaceuticals (Pharmacies) market in Panama is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic drugs and are seeking alternative options. This has led to an increase in the availability and variety of natural and herbal OTC products in pharmacies across Panama. Another notable trend is the rising popularity of online pharmacies. With the increasing penetration of internet services and the convenience of online shopping, more consumers are opting to purchase OTC pharmaceuticals online. This trend is driving the growth of e-commerce platforms specializing in healthcare products.

Local special circumstances:
Panama's unique geographic location and its status as an international trade hub have contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country's strategic position allows for easy access to a wide range of pharmaceutical products from various countries, enabling pharmacies in Panama to offer a diverse selection to consumers. Additionally, Panama's growing tourism industry has also played a role in driving the demand for OTC pharmaceuticals. Tourists often rely on pharmacies for their immediate healthcare needs, further fueling the growth of the market.

Underlying macroeconomic factors:
Several macroeconomic factors have influenced the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Panama. The country's stable economic growth and increasing disposable income levels have resulted in higher healthcare spending. This has provided consumers with the financial means to purchase OTC pharmaceuticals. Furthermore, the expanding middle class in Panama has led to an increase in healthcare awareness and a greater emphasis on personal well-being. As a result, consumers are more willing to invest in OTC pharmaceutical products to maintain their health and prevent illnesses. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Panama is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The demand for OTC pharmaceuticals is driven by the convenience and accessibility they offer, as well as the growing preference for natural and herbal remedies. Additionally, Panama's unique geographic location and its status as a trade hub contribute to the development of the market. Overall, the market is expected to continue growing as consumers prioritize self-medication and preventive healthcare.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)